Symbiotic Capital

Symbiotic Capital is a lending firm based in Los Angeles, California, established in 2022. The company specializes in providing credit solutions within the life sciences sector, focusing on supporting businesses in this industry through tailored financial products. By leveraging its expertise in life sciences, Symbiotic Capital aims to facilitate growth and innovation among its clients.

Himani Bhalla

SMD, CIO, Co-Founder

Josh Bradley

SMD and Co-Founder

3 past transactions

Caresyntax

Series C in 2024
Caresyntax Inc. is a Boston-based company that provides a digital surgery platform designed to enhance surgical performance and improve patient outcomes. The platform integrates various data sources, including video, audio, and clinical information, to deliver actionable insights for operating room (OR) teams. By leveraging advanced analytics and IoT technology, Caresyntax enables healthcare organizations to benchmark surgical outcomes, optimize resource utilization, and reduce variability in clinical performance. The software is utilized in over 4,000 operating rooms globally, supporting more than 30,000 surgeons and impacting the care of over 2 million patients each year. The company offers solutions that facilitate real-time reporting and workflow automation, allowing hospitals to mitigate risks and improve surgical training without the extensive investment typical of traditional big data analytics. Founded in 1991, Caresyntax continues to advance the use of technology in healthcare to drive better surgical practices and outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.